Correlation of Dual Energy X-Ray Absorptiometry with Markers of Bone Metabolism in Femur Fractures
Authors/Creators
- 1. Senior Resident, Department of Orthopaedics, All India Institute of Medical Sciences (AIIMS), Raipur, Chhattisgarh
- 2. Professor and Head, Department of Orthopaedics, All India Institute of Medical Sciences (AIIMS), Raipur, Chhattisgarh
- 3. Associate Professor, Department of Orthopaedics, All India Institute of Medical Sciences (AIIMS), Raipur, Chhattisgarh
- 4. Assistant Professor, Department of Orthopaedics, All India Institute of Medical Sciences (AIIMS), Raipur, Chhattisgarh
Description
Background: Numerous functions have been made possible by notable advancements in dual-energy X-ray absorptiometry (DXA) in terms of quality, picture resolution, and acquisition time. By indirectly analyzing the micro- and macroarchitecture of the bone, DXA can assess bone quality and enhance fracture risk prediction. Additionally, without the need for additional radiologic imaging or radiation exposure, DXA can identify pre-existing fractures, such as atypical femur fractures or vertebral fractures. Furthermore, it can evaluate the metabolic state by the assessment of metrics related to body composition, such as visceral fat and muscle mass. DXA is obviously useful for more than simply bone mineral densitometry, even though additional research is needed to evaluate and apply these characteristics in a clinical setting. Aim of this study to correlate bone density DUAL ENERGY X-RAY ABSORPTIOMETRY in patient with femur fracture with markers of bone metabolism. Methods: This cross-sectional analytic study was conducted at Department of Orthopaedics, AIIMS, Raipur from 24 months after obtaining ethical clearance approval, sample collection – 12 months (April 2021 to March 2022), follow up – 6 months and article writing – 6 months. Total 99 patients were enrolled in this study. Results: This study by the Department of Orthopaedics, Raipur, correlated bone metabolism markers with dual energy X-ray absorptiometry in femur fracture patients (i.e. Serum calcium; Serum phosphorus; Alkaline phosphatase; Serum Vitamin D; and Serum protein – albumin). In this study of femur fractures, 99 cases met inclusion and exclusion criteria. The mean age of the population in our study was 51.44 ± 20.44 years with range (18-97 years). The majority of population the study group was male (65.7%) as compared to females (34.3%) in our study. Majority of the population had osteoporosis (47.3%) as compared to osteopenia in 31.3% of the population and normal bone mineral density in 21.2 % population. Mode of Injury reveals that Self fall (46.5%) and RTA (44.4%) were the most common mode of injury followed by fall from height (9.1%). Intertrochanteric femur fracture (42.4%) was the most common diagnosis followed by neck of femur fracture (28.3%) shaft of femur fracture (15.2%), distal femur fracture (9.1%) and subtrochanteric femur fracture (5.1%). ANOVA showed no significant association between bone mineral density and fracture groups (p value = 0.194) nor with the DXA parameters (T-score and Z-score; p value = 0.126, 0.092 respectively). Conclusion: We found a strong correlation between advanced age and low bone mineral density, even though blood calcium, serum vitamin D, and serum phosphorus have no effect on bone density. Bone mineral density is linked to blood alkaline phosphatase, serum albumin, and fracture prediction T- and Z-scores.
Abstract (English)
Background: Numerous functions have been made possible by notable advancements in dual-energy X-ray absorptiometry (DXA) in terms of quality, picture resolution, and acquisition time. By indirectly analyzing the micro- and macroarchitecture of the bone, DXA can assess bone quality and enhance fracture risk prediction. Additionally, without the need for additional radiologic imaging or radiation exposure, DXA can identify pre-existing fractures, such as atypical femur fractures or vertebral fractures. Furthermore, it can evaluate the metabolic state by the assessment of metrics related to body composition, such as visceral fat and muscle mass. DXA is obviously useful for more than simply bone mineral densitometry, even though additional research is needed to evaluate and apply these characteristics in a clinical setting. Aim of this study to correlate bone density DUAL ENERGY X-RAY ABSORPTIOMETRY in patient with femur fracture with markers of bone metabolism. Methods: This cross-sectional analytic study was conducted at Department of Orthopaedics, AIIMS, Raipur from 24 months after obtaining ethical clearance approval, sample collection – 12 months (April 2021 to March 2022), follow up – 6 months and article writing – 6 months. Total 99 patients were enrolled in this study. Results: This study by the Department of Orthopaedics, Raipur, correlated bone metabolism markers with dual energy X-ray absorptiometry in femur fracture patients (i.e. Serum calcium; Serum phosphorus; Alkaline phosphatase; Serum Vitamin D; and Serum protein – albumin). In this study of femur fractures, 99 cases met inclusion and exclusion criteria. The mean age of the population in our study was 51.44 ± 20.44 years with range (18-97 years). The majority of population the study group was male (65.7%) as compared to females (34.3%) in our study. Majority of the population had osteoporosis (47.3%) as compared to osteopenia in 31.3% of the population and normal bone mineral density in 21.2 % population. Mode of Injury reveals that Self fall (46.5%) and RTA (44.4%) were the most common mode of injury followed by fall from height (9.1%). Intertrochanteric femur fracture (42.4%) was the most common diagnosis followed by neck of femur fracture (28.3%) shaft of femur fracture (15.2%), distal femur fracture (9.1%) and subtrochanteric femur fracture (5.1%). ANOVA showed no significant association between bone mineral density and fracture groups (p value = 0.194) nor with the DXA parameters (T-score and Z-score; p value = 0.126, 0.092 respectively). Conclusion: We found a strong correlation between advanced age and low bone mineral density, even though blood calcium, serum vitamin D, and serum phosphorus have no effect on bone density. Bone mineral density is linked to blood alkaline phosphatase, serum albumin, and fracture prediction T- and Z-scores.
Files
IJPCR,Vol15,Issue12,Article153.pdf
Files
(431.0 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:ddae10d418ca8f58248d9643a2770dc1
|
431.0 kB | Preview Download |
Additional details
Dates
- Accepted
-
2023-11-30
Software
- Repository URL
- https://impactfactor.org/PDF/IJPCR/15/IJPCR,Vol15,Issue12,Article153.pdf
- Development Status
- Active
References
- 1. Forbes AP. Fuller albright. His concept of postmenopausal osteoporosis and what came of it. Clin Orthop Relat Res. 1991; 269:128– 41. 2. Osteoporosis prevention, diagnosis, and therapy. [Last cited on 2012 Jul 09]; NIH Consens Statement. 2000 17:1–45. 3. Osteoporosis Prevention, Diagnosis, and Therapy. NIH Consensus Development Panel on osteoporosis Prevention, Diagnosis, and Therapy. JAMA. 2001; 285:785–95. 4. Mithal A, Dhingra V, Lau E, Stenmark J, Nauroy L. Nyon, Swizterland: International Osteoporosis Foundation; 2009. The Asian audit: Epidemiology, costs and burden of osteoporosis in Asia 2009. 5. Marwaha RK, Tandon N, Garg MK, Kanwar R, Narang A, Sastry A, et al. Bone health in healthy Indian population aged 50 years and above. Osteoporos Int. 2011; 22:2829–36. 6. Bone health and osteoporosis: A report of the Surgeon-General. Rockville: US Department of Health and Human Services, Office of the Surgeon General; 2004. Department of Health and Human Services. 7. Handa R. New Delhi: Osteoporosis Society of India; [Last accessed on 2012 June 26]. 2003 Action plan osteoporosis: Consensus statement of the expert group meeting; pp. 1–40. 8. Link TM. Osteoporosis imaging: State of the art and advanced imaging. Radiology. 2012; 263:3–17. 9. Genant HK, Jiang Y. Advanced imaging assessment of bone quality. Ann N Y Acad Sci. 2006; 1068:410–28. 10. Blake GM, Fogelman I. The role of DXA bone density scans in the diagnosis and treatment of osteoporosis. Postgrad Med J. 2007; 83:509– 17. 11. JJ Stepan et al. Relationship of plasma tartrateresistant acid phosphatase to the bone isoenzyme of serum alkaline phosphatase in hyperparathyroidism Clin Chim Acta (1983). 12. Ferreira A, Alho I, Casimiro S, Costa L. Bone remodeling markers and bone metastases: from cancer research to clinical implications. BoneKEy reports. 2015;4. 13. Eastell R, Hannon RA. Biomarkers of bone health and osteoporosis risk. Proc Nutr Soc. 2008; 67:157–62. 14. Shi X, Li C, Liang B, He K, Li X. Weak cation magnetic separation technology and MALDITOF-MS in screening serum protein markers in primary type I osteoporosis. Genet Mol Res. 2014; 14:15285–94. 15. Delmas PD, Eastell R, Garnero P, Seibel MJ, Stepan J, Comm Sci Advisors Int O. The use of biochemical markers of bone turnover in osteoporosis. Osteoporos Int. 2000; 11:2–17.